BIOPLUS-INTERPHEX KOREA 2025

活動詳細資訊:

Novotech will be on site at BIOPLUS-INTERPHEX KOREA 2025, connecting with biotech and pharma sponsors to discuss how our full-service CRO capabilities can support clinical development across Asia-Pacific and global regions.

Our team will be available throughout the event to explore solutions tailored to your development goals, including regulatory strategy, site activation, clinical operations, biostatistics, and project management. Whether you're planning early-phase trials or approaching market entry, Novotech provides the expertise and infrastructure to help accelerate your timeline.

If you're attending, we welcome the opportunity to meet.

Schedule a meeting with our team via the form on this page.

Novotech Attendees:

• Hyun Kim, Country Managing Director, South Korea
• Lilian Kim, Senior Director, Business Development
• Marina Mullins, Head of Therapeutic Strategy
• Jonathan Kim, Associate Director, Business Development

Schedule a meeting via the form on this page.